Veradermics, Eikon Eye Public Market Debut As IPO Tap Opens
12 Jan 2026 //
BIOSPACE
Eikon Plans IPO To Bankroll Clutch Of Clinical Cancer Drugs
12 Jan 2026 //
FIERCE BIOTECH
Eikon Therapeutics Elects David W. Meline to Board of Directors
02 Dec 2025 //
BUSINESSWIRE
Eikon to Present Ph2 EIK1001 Data in NSCLC at ESMO 2025
15 Oct 2025 //
BUSINESSWIRE
Eikon Therapeutics to Share Data at 2025 ASCO Annual Meeting
29 May 2025 //
BUSINESSWIRE
Eikon blames US cuts for 15% staff reduction
23 May 2025 //
FIERCE BIOTECH
Eikon Raises $350.7M In Series D To Advance Clinical Programs
26 Feb 2025 //
BUSINESSWIRE
Eikon’s Oblique Line Scan Tech Featured In Nature Methods
19 Feb 2025 //
BUSINESSWIRE

Market Place
Sourcing Support